Brief: ViroMed receives Brazil patent
25/04/2018 08:11
April 25 (Reuters) - ViroMed Co Ltd 084990.KQ :
* Says it received Brazil patent on April 24, for hybrid
hepatocyte growth factor gene which has a highexpression
efficiency and expresses two heterotypes ofhepatocyte growth
factor
Source text in Korean : https://goo.gl/2HRZT2
Further company coverage: 084990.KQ
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))
Recent news on Helixmith
See all newsBrief: Helixmith Announces Topline Results From Double-Blind Placebo Controlled Multicenter Study For TADIOS Involving 100 Subjects Infected With COVID-19
Brief: Helixmith Announces 50% Enrollment In Its Clinical Trial For COVID-19, Involving Tadios
Brief: ViroMed issues 2nd series convertible bonds worth 100 bln won
Brief: ViroMed appoints CEO
Brief: ViroMed receives patent